![]() Don't mix medications unless you know there are no contraindications.Ĭardiovascular: Palpitations, tachycardia, elevation of blood pressure, arythmia.Ĭentral Nervous System: Psychotic episodes at recommended doses (rare), overstimulation, restlessness, dizziness, insomnia, euphoria, dyskinesia, dysphoria, tremor, headache, exacerbation of motor and phonic tics and Tourette's syndrome. Also, if you are on any MAOI medications or medications like Buspar it can have adverse reactions. The drug should be avoided for those who have: hypersensitivity to amphetamines, a history of drug abuse, cardiovascular diseases, hypertensive disease, hyperthyroidism, or in those with glaucoma. Those who feel lower amounts of joy from dextroamphetamine have greater impulsivity improvements compared to those who feel extreme happiness. Dextroamphetamine raises decision-making scores, improves choices, and changes beliefs about rewards at the same time, dextroamphetamine barely-if at all-affects guesses of time. Short practice sessions with dextroamphetamine have a greater effect on learning than sessions without dextroamphetamine. When a person given dextroamphetamine is tested, their brain is extremely active in the brain parts required for the test and radically less active in other parts. Dextroamphetamine aids a person learning and memory of words, and perhaps makes the brain stronger. It improves self-control for people who have a hard time naturally controlling themselves. Dexedrine, along with other sympathomimetics, was eventually classified as schedule II, the most restrictive category possible for a drug with recognized medical uses.ĭextroamphetamine is useful for those with ADHD and Narcolepsy. ![]() It quickly became apparent that Dexedrine and other amphetamines had a high potential for abuse, although they were not heavily controlled until 1970, when the Comprehensive Drug Abuse Prevention and Control Act was passed by the United States Congress. Dextroamphetamine was marketed in various other forms in the following decades, primarily by Smith, Kline, and French, such as several combination medications including a mixture of dextroamphetamine and amobarbital (a barbiturate) sold under the tradename Dexamyl and, in the 1950s, an extended release capsule (the "Spansule"). In the United States, Dexedrine tablets were approved to treat narcolepsy, attention disorders, depression, and obesity. Three years later, in 1935, the medical community became aware of the stimulant properties of amphetamine, specifically dextroamphetamine, and in 1937 Smith, Kline, and French introduced Dexedrine tablets, under the tradename Dexedrine. In free-base form, amphetamine is a volatile oil, hence the efficacy of the inhalers. Notably, the chemical form of Benzedrine in the inhaler was the liquid-free base, not a chloride or sulfate salt. It was not widely marketed until 1932, when the pharmaceutical company Smith, Kline, and French (currently known as GlaxoSmithKline) introduced it in the form of the Benzedrine Inhaler, for combating cold symptoms.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |